hVIVO (United Kingdom)

Research / Science organisation


Location: London, United Kingdom (GB) GB

ROR: https://ror.org/00a4k5f23

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Relative Bioavailability of Zongertinib, an Orally Administered HER2-Selective Tyrosine Kinase Inhibitor, under Fed and Fasted Conditions in Healthy Male Participants: Results from Two Randomized, Open-Label, Crossover Studies (2025) Pereira H, Wölke S, Sadrolhefazi B, Esmaeili H, Wind S, Gan G, Müller F, et al. Journal article